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Abstract
When administered either systemically or centrally, glucose is a potent enhancer of memory processes. Measures of glucose
levels in extracellular fluid in the rat hippocampus during memory tests reveal that these levels are dynamic, decreasing in
response to memory tasks and loads; exogenous glucose blocks these decreases and enhances memory. The present
experiments test the hypothesis that glucose enhancement of memory is mediated by glycogen storage and then
metabolism to lactate in astrocytes, which provide lactate to neurons as an energy substrate. Sensitive bioprobes were used
to measure brain glucose and lactate levels in 1-sec samples. Extracellular glucose decreased and lactate increased while
rats performed a spatial working memory task. Intrahippocampal infusions of lactate enhanced memory in this task. In
addition, pharmacological inhibition of astrocytic glycogenolysis impaired memory and this impairment was reversed by
administration of lactate or glucose, both of which can provide lactate to neurons in the absence of glycogenolysis.
Pharmacological block of the monocarboxylate transporter responsible for lactate uptake into neurons also impaired
memory and this impairment was not reversed by either glucose or lactate. These findings support the view that astrocytes
regulate memory formation by controlling the provision of lactate to support neuronal functions.
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Introduction
Glucose is an important modulator of memory in multiple tasks
and species, with extensive work showing that peripheral and
central administration of glucose enhances memory and that
glucose may be an important mediator of epinephrine effects on
memory [1,2,3,4,5,6]. For example, glucose administered system-
ically to humans and rats significantly reverses age-related memory
loss when given before or after information acquisition [7,8,9,10]
and improves memory in patients with Alzheimer’s disease and
Down’s syndrome [11,12]. Moreover, meals that create a slow,
steady release of glucose improve memory in children and
individuals who have better glucose tolerance perform better at
memory tasks [10,13,14].
Although the adult brain relies heavily on glucose for its energy
needs, the extracellular glucose levels are some of the lowest in the
body, approximately 1 mM in the hippocampus vs. 5 mM in
blood [15,16,17,18]. In addition, extracellular glucose levels in the
rat hippocampus during memory tests are dynamic, decreasing in
response to memory tasks and loads [19,20,21]. In particular,
when rats are tested for memory in a 4-arm spontaneous
alternation maze, glucose levels decrease substantially; memory
is enhanced by systemic glucose administration at doses that
reverse that depletion as well as by microinjections of glucose
directly into the hippocampus [19,22]. These decreases in
extracellular glucose levels in the hippocampus are not the result
of locomotor activity or of alternation behavior per se: Rats tested
on a 3-arm maze, an easier task for rats due to the lower working
memory load of three versus four locations, make a similar
number of arm entries. However, the rats exhibit only slight
decreases in extracellular glucose levels and memory is not
improved by glucose injections [21]. These findings suggest that
basal glucose levels are sufficient for the energy demands of the
easier task but not the harder one.
While the mechanism by which glucose acts on the brain to
regulate memory is unclear, there is evidence that glucose
augments training-related release of acetylcholine in the hippo-
campus [8,22,23,24], an effect that may participate in glucose
enhancement of memory. In addition, glucose effects on memory
may include downstream effects mediated by the mammalian
target of rapamycin (mTOR) pathway to promote mechanisms of
neuronal plasticity [25]. mTOR is itself down-regulated by
activation of the metabolic sensor, AMP-activated protein kinase
(AMPK) [26], in response to cellular energy stress as might occur
during training-associated decreases in glucose availability. Recent
evidence suggests that the coordinated functions of mTOR and
AMPK up- and down-regulate neuronal plasticity, respectively
[27].
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both beginning with circulating glucose. The first is glucose entry
into neurons with subsequent oxidative metabolism. In addition to
direct entry of glucose into neurons, a second source is provided by
glucose entry into astrocytes. Unlike neurons, astrocytes store
glycogen that can be rapidly metabolized upon activation to
initiate glycogenolysis, thereby providing lactate as an energy
substrate transported to neurons. Thus, astrocytic storage of
glycogen provides a supplemental energy reserve available to
neurons when demand is high [28,29,30,31,32].
While glucose uptake into neurons and astrocytes is about equal
at baseline, recent findings show that whisker stimulation of
somatosensory neocortical activity results in a preferential increase
in glucose uptake into astrocytes [33]. Together, these findings
lead to a general hypothesis that basal brain extracellular glucose
levels can fulfill neuronal energy requirements under low-need
conditions but, when the need is greater, for example during more
intense cognitive functions, astrocytic glycogenolysis is activated to
provide lactate, which is transported to neurons to provide a rapid
boost from energy reserves when extracellular glucose levels are
not sufficient to maintain optimal function.
The functional significance of this reserve for learning and
memory is supported by recent findings that interference with
lactate transport from astrocytes into neurons impairs long-term
potentiation and long-term memory for an inhibitory avoidance
task [32]. The transport is mediated by monocarboxylate
transporters (MCTs) distinctly localized on astrocytes (MCT1
and MCT4), to release lactate, and neurons (MCT2) to admit
lactate [34,35,36]. Because pretraining injections of a lactate
transport inhibitor did not impair memory tested 1 hr after
training, the authors concluded that astrocytic glycogenolysis was
selectively necessary for long- but not short-term memory.
The present experiments examine possible astrocytic involve-
ment in a spontaneous alternation task, in which spatial working
memory is assessed during short-term memory tests. Supporting
the idea that memory in the spontaneous alternation task might be
mediated by astrocytic glycogenolysis, previous findings indicate
that systemic and central injections of glucose enhance memory in
this task and reverse age-related memory impairments. Figure 1
illustrates the model tested here with pharmacological and
neurochemical methods to evaluate the significance for memory
of astrocytic glycogen metabolism to lactate and transport to
neurons. In the present experiments, changes in extracellular
lactate and glucose levels were assessed with bioprobes, enabling
sampling every second. The roles of lactate and glucose in memory
were further evaluated with selective pharmacological agents to
block glycogenolysis [37] and MCT2 [38].
Methods
Subjects
Male, Sprague-Dawley rats (Harlan Laboratories; 3 months old
at the time of surgery) were housed individually with free access to
food and water and maintained on a 12:12 hr light/dark cycle
with lights on at 7:00 am. All procedures described in this paper
were approved by the University of Illinois Urbana-Champaign
Institutional Animal Care and Use Committee in accordance with
guidelines outlined in Guide for Care and Use of Laboratory Animals and
accredited by the Association for Assessment and Accreditation of
Laboratory Animal Care.
Surgeries
Rats were anesthetized with isoflurane and placed in a
stereotaxic frame. In studies of the effects on memory of
intrahippocampal drug infusions, two 8-mm guide cannulae
(Plastics One) were chronically implanted bilaterally above the
central portion of the ventral hippocampus (coordinates: 5.5 mm
posterior and 64.8 mm lateral from bregma and 4.2 mm ventral
from skull) to accommodate infusion cannulae near the time of
behavioral testing. Due to the shape and size of the housing for the
wireless potentiostat used for measurements of changes in
extracellular glucose and lactate levels during behavioral testing,
the guide cannula for bioprobes needed to be placed close to the
midline of the skull. Therefore the guide cannulae for bioprobes
were implanted above the dorsal hippocampus instead of the
ventral hippocampus in either the left or right hemisphere
(coordinates: 3.8 mm posterior and 2.5 mm lateral from bregma
and 1.9 mm ventral from skull). We have previously found that
direct infusions of glucose into either the dorsal [39] or ventral
[22,24] hippocampus were both effective in enhancing memory
during spontaneous alternation testing. All rats were allowed at
least 1 week to recover after surgery during which rats were
handled 3 min each day for 5 consecutive days prior to behavioral
testing.
Memory testing
Spatial working memory was assessed using spontaneous
alternation tasks [cf: 40,41,42]. Spontaneous alternation was
chosen to assess memory because it requires no food reward and
thus no food restriction; therefore the natural levels of glucose or
lactate would be at baseline at the start of testing. The task was
also chosen because it measures spatial working memory, which is
sensitive to hippocampal manipulations. In the current experi-
ments, animals were placed on a four-arm, plus-shaped maze
(arms: 45 cm long, 14 cm wide, 7.5 cm tall; center area:
14614 cm) constructed of opaque, black Plexiglas, as described
previously [22,23,24] or in a four-arm, plus-shaped maze with
slightly higher sides (45 cm long, 14 cm wide, and 15 cm tall;
center area: 14614 cm) that were made of clear Plexiglas. The
maze with higher arms was used to contain the rats better on the
maze in experiments in which a delay was imposed between arm
choices [43,44]. The maze was located in the center of the testing
rooms on a table 76 cm above the floor surrounded by a rich
assortment of extra-maze visual cues. During each testing session,
the rat was placed in a start arm and allowed to explore the maze
freely for 20 min while the number and sequence of arm entries
were recorded. An alternation was defined as when the rat visited
all four arms within a span of five choices. Thus, five consecutive
arm choices during a testing session comprised a quintuple set. As
examples, a quintuple set consisting of arm choices A,B,D,A,C was
considered an alternation but a quintuple set consisting of arm
choices A,B,D,A,D was not considered an alternation. Using this
procedure, possible alternation sequences are equal to the number
of arm entries minus 4. The percent alternation score is equal to
the ratio of actual alternations/possible alternations 6100; chance
performance using this measure is 44%.
Intrahippocampal injections of lactate were expected to
enhance memory scores. To prevent a ceiling effect in memory
scores, a delay of 20 sec was introduced between each arm entry.
After the rat entered the first four arms, a barrier was placed at the
end of the fifth choice to prevent the rat from leaving the arm for
20 sec. The first four choices made without the 20-second delays
were not included in the calculations of spontaneous alternation
scores.
All other pharmacological experiments examined impairments
of memory with drugs that block lactate delivery from astrocytes to
neurons, together with possible reversals of these impairments with
co-administration of glucose or lactate. No delay between arm
Astrocytes and Memory
PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e28427entries was imposed during these experiments or in the experiment
measuring changes in extracellular glucose and lactate during
maze testing.
The pharmacological manipulations were performed as within-
subjects testing of multiple doses. Each testing session occurred in
a new room with new extramaze visual cues to encourage
sufficient exploratory behavior. Additionally, an interval of at least
48 hrs was imposed between testing sessions to allow sufficient
time for drugs to clear the animal’s system. To ensure an accurate
assessment of spontaneous alternation, only rats that made a
minimum of ten arm entries (6 possible alternations) during the 20-
minute test were included in the final analysis.
Bioprobe measurements of extracellular hippocampal
glucose and lactate during behavioral testing
Either a glucose- or a lactate-sensitive biosensor was inserted
into the dorsal hippocampus via a guide cannula (Pinnacle
Technology Inc., Lawrence, KS). The biosensor projected 3 mm
beyond the end of the implanted cannula. The last 1 mm of the
probe was coated with lactate oxidase or glucose oxidase to
metabolize the respective analyte, generating a current measured
by the probe. The biosensor was connected to a potentiostat inside
the head cap, which sent readings of the current generated by
lactate or glucose in extracellular fluid to a computer by telemetry,
with data recording and storage in 1-sec bins accomplished with
Pinnacle Technology Laboratory v. 1.6.7 software. Glucose
biosensors have previously been shown to have a range of 0–
10 mM with in vitro sensitivity of 1.660.4 nA/mM (mean 6 SEM)
and lactate biosensors have a range of 0–8 mM with an in vitro
sensitivity of 4.660.6 nA/mM (mean 6 SEM) [45,46]. To
confirm the accuracy of the biosensors prior to implantation and
immediately following testing, the probe was placed in 0.1 M PBS,
connected to the potentiostat, and readings were allowed to
stabilize (generally stable within 15–30 minutes). After a stable
baseline reading over at least 4 minutes was recorded for the
lactate probe, lactate was added to the PBS in 20 mM increments
every 1.5 minutes to establish the nA/mM ratio. For the glucose
probe, glucose was added to the PBS in 500 mM increments.
Because the probes have been shown to measure ascorbic acid,
they are coated with a selective membrane containing ascorbate
oxidase to break down the ascorbic acid so it is not measured by
the biosensor. To ensure this layer is intact, 250 mM of ascorbic
acid was added to the PBS solution two times. No other substrates
have been shown to be measured by the biosensors [45,46]. Four
rats were tested with the lactate biosensor and four rats were tested
with the glucose biosensor. Biosensors were inserted into the guide
cannula at least 4–5 hours prior to testing on spontaneous
alternation. For graphical presentation in this report, the
recordings are presented here as averages across 10 sec. Baseline
values were determined using the 5 min prior to the start of
spontaneous alternation and all results are reported as a percent
change from baseline. The results were then analyzed statistically
using comparisons at baseline, 0.5, 5 min, 10 min, and 15 min
into spontaneous alternation testing as well as at 0, 0.5, and 5 min
after the end of testing.
Intrahippocampal Injections to enhance or impair
memory
All injections (0.5 ml, 0.9% saline vehicle, pH=7.2) were made
bilaterally into the ventral hippocampus with a CMA/100
microinjection pump at a flow rate of 0.25 ml/min 5 min prior
to behavioral testing. Ten rats were injected with lactate (0, 50,
100, or 150 nmol of lactate in 0.5 ml of 0.9% saline, pH=7.2), 12
rats were injected with 1,4-dideoxy-1,4-imino-D-aribinitol (DAB;
0, 0.5, 5, 50 pmol, 50 pmol+25 nmol glucose, or 50 pmol+50 n-
mol lactate in 0.5 ml of 0.9% saline, pH=7.2), and 8 rats were
injected with a-cyano-4-hydroxycinnamate (4-CIN; 3, 10,
30 pmol, 30 pmol+25 nmol glucose, or 30 pmol+50 nmol lactate
Figure 1. Model of astrocytic contribution of lactate to memory processing. Pharmacological tests and measures of many aspects of this
figure were tested in the present experiments. DAB: 1,4-dideoxy=1,4-imino-D-aribinitol, 4-CIN: a-cyano-4-hydroxycinnamate, MCT: monocarboxylate
transporter.
doi:10.1371/journal.pone.0028427.g001
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into the hippocampus 5 min prior to behavioral testing. DAB, an
inhibitor of glycogen phosphorylase, was used to block glycogen-
olysis in astrocytes [32,37,47]. Low doses of 4-CIN were used to
block the neuronal transporter, MCT2, while not blocking
astrocytic MCT1 or MCT4 transporters [34,35,48,49,50,51,
52,53]. Doses were given in a counterbalanced order using a
Latin squares design with each main treatment tested in separate
groups of rats. In the DAB and 4-CIN experiments, the maximum
doses (50 pmol of DAB or 30 pmol of 4-CIN) were co-
administered with either 25 nmol of glucose or 50 nmol of lactate
in a counterbalanced order after the dose-response curve had been
defined to test whether impairments induced by DAB or 4-CIN
could be reversed by either glucose or lactate. Because each
glucose molecule yields two lactate molecules, the molar dose of
lactate was twice that of glucose to match the stoichiometry
[32,54]. Because 25 nmol of glucose is similar to doses that have
been demonstrated to enhance memory,15, 50 and 150 nmol of
lactate were chosen to assess whether lactate could enhance
memory to include an optimal dose (50 nmol) as well as a dose
that is higher (150 nmol) and lower (15 nmol) [55,56].
Histology for glycogen localization and for cannula
placements
On completion of testing, rats received an overdose of sodium
pentobarbital followed by intracardial perfusion with ice-cold 4%
paraformaldehyde in 0.1 M PBS. Brains were removed and
postfixed overnight in 4% paraformaldehyde. They were then
transferred to a 20% glycerol solution until they lost buoyancy
(,48 hrs). They were then sectioned on a cryostat (Leica
CM1850, Leica Microsystems Inc., Germany) with 20 mm slices
of prefrontal cortex, striatum, dorsal hippocampus, and ventral
hippocampus saved for glycogen localization analysis using a
periodic acid-Schiff’s reagent method (PAS) previously demon-
strated to highlight glycogen [57]. Prior to PAS staining,
immunofluorescence methods were used to stain neurons with
neuronal nuclear antigen (NeuN) and astrocytes with glial fibrillary
acidic protein (GFAP) so that all sections were stained with PAS
and consecutive sections were stained for NeuN and GFAP.
Briefly, for GFAP immunofluorescence, the tissue was rinsed in
0.05 M PBS 46 for 10 minutes and then incubated in a 5%
normal goat serum (NGS), 1% bovine serum albumin (BSA), and
0.2% Triton X-100 in 0.05 M PBS for 60 minutes to block
endogenous proteins. Next, the tissue was transferred a solution
containing 5% NGS, 1% BSA, 0.2% Triton X-100 and 1:2000
dilution of Rabbit anti-GFAP (Millipore # AB5804) in 0.05 M
PBS overnight at room temperature. Sections were then rinsed 46
in 0.05 M PBS for 10 minutes each. Finally the tissue was
incubated for 2 hours in 1% NGS, 0.2% Triton X-100, and
1:2000 dilution of Goat anti-rabbit Alexa Fluor 488 (Invitrogen
#A11008). For NeuN immunofluorescence, the same rinsing and
blocking procedures were followed. The tissue was then incubated
in 5% NGS, 1% BSA, 0.2% Triton X-100 and 1:2000 dilution of
Milli-Mark FluoroPan Neuronal Marker ( Mouse IgG conjugated
with Alexa 488; Millipore # MAB2300X) in 0.05 M PBS
overnight at room temperature. All tissue was then mounted on
silated slides and stained for glycogen. The PAS method used was
previously described [57,58]. Briefly, slides were oxidized in 0.5%
periodic acid for 10 min at room temperature and then incubated
in a saturated solution of dimedone in 80% ethanol for 1 hour at
60uC. After rinsing in distilled water slides were reacted in Lillie’s
cold Schiff’s reagent for 30 minutes. Slides were next rinsed in
running tap water for 5 minutes. Slides were then dehydrated,
delipidated using Histoclear and coverslipped. Photomicrographs
of the tissue were collected using a Leica CTR6000 microscope, a
Leica DM600B camera, and Leica Application Suite (v. 3.7.0,
Leica Microsystems Inc., Germany). The PAS stain fluoresces at
an excitation wavelength around 525 nm and can be visualized
using a red light (rhodamine) fluorescent filter [59,60,61]. Images
were captured for each slice with the rhodamine and fitc (green)
filters (for GFAP or NeuN). Images were then compiled using
Photoshop v. 6.0 to look for colocalization.
Forty-mm sections were also taken from the same brains around
the areas of cannula implantations to confirm placements using
cresyl violet. Photomicrographs were taken using Image Pro
Express (v. 5.1.0.12, Media Cybernetics, Inc., Bethesda, MD). No
data had to be excluded from rats with either extensive tissue
damage or from rats where the placement was outside the target
brain structure; however one rat was excluded from the DAB
experiment because it died prior to the completion of data
collection. Two rats were excluded from the 4-CIN study; one
developed seizures and the other removed one cannula prior to
completion of data collection. Lastly, one rat implanted with a
glucose biosensor was excluded because it failed to navigate the
maze during the spontaneous alternation test.
To show that 4-CIN did not block monocarboxylate transport
into mitochondria, activity of the mitochondria was monitored
using a stain for succinate dehydrogenase (SDH) activity [62,63].
SDH activity has previously been demonstrated to decrease in the
presence of 3-bromopyruvate and with sensory deprivation
[62,63,64] supporting a relationship between SDH activity and
mitochondrial function. Prior to sacrifice, the rats used in the 4-
CIN dose response experiment received 30 pmol 4-CIN unilater-
ally in the ventral hippocampus and 1% DMSO in saline in the
other hemisphere, providing within-subjects comparisons. The
hemispheres receiving 4-CIN were counterbalanced across rats.
Five min after the injection animals were tested on spontaneous
alternation for 20 minutes to parallel the other behavioral
experiments. The rats then received an overdose of sodium
pentobarbital and were perfused transcardially with 10% glycerol
and 0.5% paraformaldehyde in PBS. The brains were removed,
blocked, frozen rapidly in heptane cooled with dry ice, and
sectioned in the coronal plane at 30 mm in a cryostat. Alternating
40 mm sections were saved from ventral hippocampus for cresyl
violet nissl staining to determine cannulae placements and staining
for SDH activity using methods previously described [62,65]. The
colorimetric change reflecting SDH activity was then assessed for
optical density using ImageJ 1.43n (National Institutes of Health,
USA, http://rsb.info.nih.gov/ij). In ventral hippocampus, sepa-
rate measures were taken from CA1, CA3 and the dentate gyrus.
Statistical Analysis
All statistical analyses were done using SPSS v. 18.0 (SPSS,
Chicago, IL). For each experiment, repeated measures ANOVAs
were used to analyze differences. Fisher’s least significant
difference post hoc tests were conducted when the results from
the ANOVAs were significant.
Results
Glycogen is in astrocytes, not neurons
As shown in Figure 2, astrocytes immunolabeled with GFAP
(left) and neurons immunolabeled with NeuN (right) in the dentate
gyrus are stained green. Glycogen colocalized with GFAP or
NeuN is stained yellow. As evident in this figure, glycogen staining
was colocalized with astrocytes but not with neurons. These
findings support past results [66,67,68,69]. The colocalization is
especially prominent in the molecular layer and the hilus of the
Astrocytes and Memory
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dendrites and the axonal regions where energy demands would be
expected to be higher than in the cell layers [17,70,71]. Similar
results (not shown here) were also seen in the prefrontal cortex,
striatum, and ventral hippocampus with colocalization of glycogen
and GFAP but no colocalization with NeuN.
Lactate and glucose levels increase and decrease,
respectively, during behavioral testing
Recordings from bioprobes before, during and after memory
testing revealed substantial increases in extracellular hippocampus
levels of lactate and decreases in extracellular levels of glucose
beginning with the placement of the rat on the maze (Figure 3).
Extracellular lactate concentrations significantly increased in the
first 30 sec of testing on the maze (t3=4.77, p,0.02) while glucose
levels did not significantly decrease until 5 min into testing
(t2=3.58, p,0.05). Both lactate and glucose levels returned
toward baseline after about 10 min of testing, while the rats were
still performing on the maze (baseline vs. 10 min: lactate, p=0.12;
glucose, p=0.47) however at 15 minutes after the start of testing,
lactate levels were significantly higher than baseline (t3=4.47,
p,0.05). The initial decreases and later increases in extracellular
glucose levels are consistent with those we have seen before with 5-
min sampling obtained with microdialysis procedures in the
hippocampus during similar spontaneous alternation testing; the
increase in extracellular glucose late in testing corresponds to an
increase in blood glucose levels during training [19,21].
A slight second increase in lactate was evident when the rats
were removed from the maze and replaced in their home cages
(t3=3.27, p,0.05). This could indicate that the arousal of
handling was sufficient to elicit these fluxes in lactate and supports
previous findings that stress can elicit lactate production from glial
cells [72]. However this effect at the end of testing was not as great
or as long-lasting as was the rise in lactate during testing. It should
also be noted that while no memory processing was measured
behaviorally at the time of handling-related increases in lactate, it
is likely that memory of the handling experience may also be
formed in this experiment as in other experiments of this type.
Intrahippocampal infusions of lactate enhance memory
Injections of lactate directly into the hippocampus prior to
testing enhanced memory on the delayed version of the
spontaneous alternation task (F3,27=4.04, p,0.02; Figure 4).
The enhancement of memory by lactate followed an inverted-U
dose response curve in a manner similar to that seen previously
with systemic and intrahippocampal injections of glucose
[23,55,73]. In past studies of intrahippocampal injections of
glucose, the optimal dose was ,20 nmol [55]. This value is
approximately half the optimal dose of lactate, consistent with two
lactates produced for each glucose metabolized [20,32,54,55].
There were no significant differences in the total arm choices the
animals made across doses (p.0.9). There were also no differences
across the counterbalanced testing sessions confirming there were
no overall improvements or impairments due to repeated
spontaneous alternation testing (p.0.3).
Inhibition of glycogenolysis impairs memory, an effect
reversed by addition of glucose or lactate
DAB was used to inhibit glycogen phosphorylase and to limit
the production of lactate from glycogen in astrocytes. DAB
injections into the hippocampus significantly impaired alternation
scores (F3,33=15.48, p,0.001; Figure 5). The impairment was
evident at both the 5 and the 50 pmol doses (Percent Alternation
6 SEM: Saline=71%63.7% vs. 5 pmol DAB=58.8%63.6%,
p,0.02 and vs. 50 pmol DAB=41.6%63.2%, p,0.001). The
total number of arm choices did not differ across doses (p.0.6).
Injections of either 25 nmol of glucose or 50 nmol of lactate
together with the higher DAB dose significantly reversed the
memory impairments (Percent Alternation 6 SEM: 50 pmol
DAB=41.6%63.2% vs. 25 nmol of glucose and 50 pmol
DAB=62.6%63.1%, p,0.001 and 50 nmol of lactate and
50 pmol DAB=56.2%62.9%, p,0.01).
Blocking lactate transport into neurons impairs memory,
an effect not reversed by addition of either lactate or
glucose
Preferential blockade of the MCT2 by intrahippocampal injections
of 4-CIN significantly impaired alternation scores (F3,15=4.52,
p,0.03; Figure 6). The impairment was seen at both the 10 pmol
and the 30 pmol doses (Percent Alternation 6 SEM: 1% DMSO in
Saline=65.2%64.9% vs. 10 pmol 4-CIN=47.4%64.7%, p,0.05
and 30 pmol 4-CIN=39.8%63.3%, p,0.05). The total arm choices
made did not differ across doses (p.0.9). Importantly, the addition of
either 25 nmol of glucose or 50 nmol of lactate to the 30 pmol dose
of 4-CIN did not significantly improve working memory (all p.0.1).
In the ventral hippocampus, CA1, CA3 and DG were
individually analyzed for optical density using Paxinos and Watson
(2003) as a reference. The area of interest was highlighted and a
minimal threshold was used to exclude portions that did not
contain stained tissue (e.g. capillaries) and kept constant across
animals. No significant differences in SDH activity were seen
between the hemisphere that received 30 pmol of 4-CIN and the
hemisphere that received 1% DMSO in saline across the assessed
areas of the ventral hippocampus (Ns=4; p.0.1, Figure 7).
Discussion
The data reported here support the view that, in the
hippocampus, glycogenolysis in astrocytes, and subsequent
delivery of lactate to neurons, is important for spatial working
memory. Within the hippocampus, glycogen was localized to
astrocytes and not neurons, consistent with other evidence that
astrocytes are the prime source of glycogen in the brain
[28,29,69,74,75]. There are still some who argue glycogen is
found in neurons as well, which could be due to the transient
appearance of glycogen in neurons during development [76] or
the appearance of glycogen in neurons in glycogen storage diseases
[77,78,79]. Glycogen was further localized to the molecular layer
and hilus, as compared to the dentate granule cell layer [80]; the
synapse dense molecular layer is likely to be a subregion especially
Figure 2. Immunolabeling of astrocytes using GFAP and
staining for glycogen using a Periodic Acid Schiff’s Reaction
(PAS) demonstrated colocalization (in yellow) of glycogen and
astrocytes (left). Immunolabeling of neurons using NeuN and
glycogen with PAS showed no colocalization (in yellow) of glycogen
in neurons (right).
doi:10.1371/journal.pone.0028427.g002
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lactate- and glucose-specific biosensors, extracellular concentrations of both lactate and glucose were measured during spontaneous alternation
testing. Lactate concentrations significantly increased at the beginning of behavioral testing (n=4; t3=4.77, p,0.02; MEAN 6 SEM: 112.50%63.15%).
In contrast, glucose concentrations decreased after 5 minutes on the task (n=3; t2=3.58, p,0.05; MEAN 6 SEM: 86.19%67.73%). The increase in
extracellular glucose seen 5–10 min after the start of memory testing corresponds to an increase in blood glucose levels (baseline vs. 10 min: p=0.47,
10 min MEAN 6 SEM: 103.68%66.29%). After the rat was removed from the maze there was a significant increase in lactate compared to baseline
levels (t3=4.77, p,0.02; MEAN 6 SEM: 117.9%62.87%) most likely due to handling.
doi:10.1371/journal.pone.0028427.g003
Figure 4. Enhancement of memory with intrahippocampal injections of lactate. Lactate injected into the ventral hippocampus 5 min
before testing improved the percent alternation scores on a 4-arm delayed spontaneous alternation task at the 50 nmol dose (n=10; F3,27=4.04,
p,0.02; Percent Alternation 6 SEM: Saline=34.5%68.9% vs. 50 nmol Lactate=61.2%66.5%). Higher and lower doses of lactate did not significantly
improve alternation scores.
doi:10.1371/journal.pone.0028427.g004
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neural functions [17,81].
Using bioprobes to measure extracellular lactate and glucose
levels in the hippocampus with 1-sec sampling, the present findings
indicate that lactate levels increase, and glucose levels decrease,
during alternation testing. The decrease in glucose levels is
consistent with prior evidence obtained with slower 5-min in vivo
microdialysis samples [18,21]. Of note, the decrease in glucose
Figure 5. Impairment of memory by DAB injections, used to inhibit glycogenolysis. The impairment was reversed by lactate or glucose,
which can act downstream of glycogenolysis. 1,4-dideoxy-1,4-imino-D-arabinitol (DAB) injected into the ventral hippocampus 5 min prior to testing
significantly impaired scores on a 4-arm spontaneous alternation task (n=12; Percent Alternation 6 SEM: Saline=71%63.7% vs. 5 pmol
DAB=58.8%63.6%, p,0.02 and vs. 50 pmol DAB=41.6%63.2%, p,0.001). The performance deficit created by 100 mM of DAB was significantly
reversed by the co-administration of 100 mM lactate or 50 mM glucose (Percent Alternation 6 SEM: 50 pmol DAB=41.6%63.2% vs. 25 nmol of
glucose and 50 pmol DAB=62.6%63.1%, p,0.001 and 50 nmol of lactate and 50 pmol DAB=56.2%62.9%, p,0.01).
doi:10.1371/journal.pone.0028427.g005
Figure 6. Impairment of memory by 4-CIN injections, used to block MCT2. The impairment was not reversed by either lactate or glucose.
Blockade of the MCT-2 with 4-CIN impaired working memory in a dose-dependent manner (n=6; Percent Alternation 6 SEM: 1% DMSO in
Saline=65.2%64.9% vs. 10 pmol 4-CIN=47.4%64.7%, p,0.05 and 30 pmol 4-CIN=39.8%63.3%, p,0.05). This impairment was not significantly
reversed with the addition of either lactate or glucose (ps.0.1).
doi:10.1371/journal.pone.0028427.g006
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activity since the decrease was not seen on a similar alternation
task with comparable motoric activity but lower cognitive
demands [21]. Also, the rise in hippocampal glucose levels while
the rats remain on the maze during testing corresponds to a rise in
blood glucose levels, probably subsequent to epinephrine release
from the adrenal medulla into blood and initiation of hepatic
glycogenolysis, while the rats are tested [21].
The reciprocal relationship between lactate and glucose
responses to memory testing suggests that glucose and lactate
work in concert to maintain the energy capacity of neurons, as
appears evident also in the dentate gyrus after perforant path
stimulation [45] and in somatosensory cortex after whisker
stimulation [33]. While it is clear that the increased levels of
lactate are mirrored by decreased levels of glucose in the beginning
of testing, the levels of extracellular lactate stay above baseline for
the duration of spontaneous alternation testing even as glucose
levels return to baseline values, suggesting that lactate may not just
be a compensatory substrate but may be important for
maintaining working memory processing.
The importance for memory of the increases in lactate was
supported by a set of pharmacological findings showing that
lactate provision from astrocytes to neurons is necessary for
memory processing. Lactate itself, in the absence of other
(impairing) treatment enhanced memory in the alternation task.
These findings are similar to those observed previously with
intrahippocampal glucose injections [8,16,20]. The inverted-U
dose-response function for memory enhancement is typical of
many cognitive enhancers, including glucose [3,101,102,103,104];
while this effect has been shown repeatedly, there is no consensus
regarding its neurobiological bases. The glycogen phosphorylase
inhibitor, DAB, impaired memory when injected into the
hippocampus; the impairment was mitigated by either lactate or
glucose. While the lactate most likely was directly taken up by the
neurons, it was unclear from these data whether the glucose was
being taken up by the neurons or the astrocytes in order to rescue
memory after impairment by DAB. As illustrated in Figure 1,
astrocytes could have provided lactate to neurons either through
glycolysis or glycogenolysis. However, additional findings indicat-
ed that MCT2 blockade also impaired memory and that the
impairment was not reversed by either glucose or lactate. The
blockade of the MCT2 transporter should not affect the ability of
neurons to admit glucose through the main neuronal glucose
transporter GLUT3 [105,106]. Thus, the current data suggest that
lactate, provided by astrocytes via glycolysis or glycogenolysis, may
be an important substrate for neurons during working memory by
providing rapid additional energy at times of high need. As shown
here, that need can be generated by cognitive demands.
The findings reported here are largely consistent with past
examinations of lactate derived from astrocytes in regulating
memory processing in chicks [107,108,109] and laboratory
rodents [32]. In addition, memory after inhibitory avoidance
training and long-term potentiation were impaired by interference
with MCT1 and these impairments were reversed by lactate. In
rats, training-related expression of molecular factors often
associated with memory, pCREB and Arc, were also blocked
after inhibition of MCT1 and these effects too were rescued by
lactate [32]. Although the previous work focused on lactate
contributions to consolidation of long-term memory, and included
the suggestion that lactate was not necessary for short-term
memory, the present findings reveal an important role for lactate
in spatial working memory assessed with short-term tests,
suggesting that the role of astrocytes and lactate include supporting
short-term memory processing as well as the formation of long-
term memories.
With the 1-sec sampling method used here to measure fluxes in
extracellular lactate and glucose levels; it appears that the rise in
extracellular lactate slightly precedes the decrease in glucose. This
finding suggests that the astrocytic responses may anticipate
energy needs rather than responding to them. In this regard, it is
important to note that glycogenolysis in astrocytes can be initiated
by activation of ß-adrenergic receptors on astrocytes [82,83,84].
Other neurotransmitters are likely involved as well, with evidence
revealing several signals that can lead to glycogenolysis in
astrocytes. These signals include neurotransmitters and modula-
tors such as glutamate, GABA, vasoactive intestinal peptide,
acetylcholine, serotonin, norepinephrine, dopamine, adenosine
and insulin [85,86,87,88,89,90,91,92,93,94,95]. Some of these
same modulators have also been shown to increase glucose
transport into the astrocytes [96,97,98] and this increased glucose
transport has been associated with learning and memory [99,100].
These and other neurotransmitters have received attention in
regulating memory processing, with interpretations based on
direct neural actions of the transmitters and related drugs and
other interventions. Given the breadth of neurochemical signals
that act on astrocytic receptors, and possibly then on lactate
production, it may be important to revisit the effects of many
neurotransmitter-related treatments that enhance memory to
determine which drugs act indirectly on neurons via regulation
of astrocytes to provide energy substrates available for neurons.
Together, these findings suggest that astrocytes may play an
important role in neural plasticity and memory [29,31,
32,96,109,110]. The neurochemical and pharmacological results
are consistent with the hypothesis, illustrated in Figure 1, in which
lactate is released from astrocytes and ‘shuttled’ to neurons for
energy metabolism (as in [29,111]). It must be noted that there is
not uniform agreement about the role for lactate in providing
energy for brain function [112]. In part, as presented in recent
reviews [17,112], the disagreement results from a dearth of
Figure 7. Representative histology showing SDH activity in the
ventral hippocampus. In this example, the left hemisphere received
infusions of 1% DMSO in saline (left) and the right hemisphere received
infusions of 30 pmol 4-CIN. There were no significant differences in
optical density between ventral hippocampal areas receiving 30 pmol
of 4-CIN or 1% DMSO in saline in CA1, CA3, or dentate gyrus (n=6;
p.0.1).
doi:10.1371/journal.pone.0028427.g007
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brain ECF glucose levels to those of ECF lactate levels under
normal physiological conditions. The present findings address this
issue directly with experiments showing that lactate levels increase
when glucose levels decrease.
Although the focus of the present report is on metabolic
contributions to modulation of memory, there are other ways that
astrocytes may contribute to memory and other neural functions.
These need not be seen as mutually exclusive and include:
neurotransmitter clearance to inactivate neurotransmitters by
uptake mechanisms; as one of the elements of the ‘‘tripartite
synapse’’ [113,114], with astrocyte, pre- and postsynaptic neural
elements functioning in integrative manner to control excitability
and to reshape synapse morphology (e.g., [115,116,117,118,
119,120]); synthesis and release of D-serine into extracellular
space, where serine functions as an NMDA receptor co-agonist to
promote long-term potentiation [121]; synthesis and release of
ephrin-A3 in the hippocampus [122], which may regulate glial
glutamate transport, and synapse morphology [118]. Together,
there is growing evidence that astrocytes participate actively and
importantly to memory processing and neural plasticity, requiring
careful attention to the contributions of these varied astrocytic
mechanisms for memory.
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